Changes in ceramide and sphingomyelin following fludarabine treatment of human chronic B-cell leukemia cells
Authors:
- Kaushik DattaKDKaushik Datta
- George K Acquaah-MensahGAGeorge K Acquaah-Mensah
- James P KehrerJKJames P Kehrer
- 1 November 2000
- journal article
- Published by Elsevier in Toxicology
- Vol. 154 (1-3) , 45-53
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Ceramide-induced killing of normal and malignant human lymphocytes is by a non-apoptotic mechanismOncogene, 1999
- On the complexities of ceramide changes in cells undergoing apoptosis: lack of evidence for a second messenger function in apoptotic inductionCell Death & Differentiation, 1999
- Bcl-xL overexpression attenuates glutathione depletion in FL5.12 cells following interleukin-3 withdrawalBiochemical Journal, 1997
- Bcl‐2 antagonizes apoptotic cell death induced by two new ceramide analoguesFEBS Letters, 1997
- Chemotherapy-Induced Apoptosis1997
- Ceramide induces apoptosis via CPP32 activationFEBS Letters, 1996
- The vitamin D3 analogue, calcipotriol, induces sphingomyelin hydrolysis in human keratinocytesFEBS Letters, 1996
- Ceramide synthase mediates daunorubicin-induced apoptosis: An alternative mechanism for generating death signalsCell, 1995
- 1-beta-D-Arabinofuranosylcytosine stimulates ceramide and diglyceride formation in HL-60 cells.Journal of Biological Chemistry, 1994
- Glutathione measurement by high-performance liquid chromatography separation and fluorometric detection of the glutathione-orthophthalaldehyde adductAnalytical Biochemistry, 1989